NEVVI Medicare utilization intelligence

← back

Provider profile

KILDAY, PATRICK MD

Urology · NPI 1972862613 · SACRAMENTO, CA

1
Groups
30
Codes · 2024
5,338
Disclosed services

KILDAY, PATRICK is a Urology in SACRAMENTO, CA, a member of 1 medical group, who billed 30 distinct codes to Medicare Part B in 2024.

Groups: SUTTER VALLEY MEDICAL FOUNDATION (SACRAMENTO, CA)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider analytics (2024)

KILDAY, PATRICK billed 3,483 disclosed services in CY2023 and 5,338 in CY2024.

This provider's disclosed Medicare payments across all codes were $premium in CY2024.

The full figure is part of the market analytics platform — built, not launched yet. Notify me at launch →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J9030 Bcg live intravesical instillation, 1 mg premiumpremium premiumpremium
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more premiumpremium premiumpremium
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more premiumpremium premiumpremium
51798 Ultrasound measurement of bladder capacity after voiding premiumpremium premiumpremium
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's premiumpremium premiumpremium
81003 Automated urinalysis test premiumpremium premiumpremium
J0696 Injection, ceftriaxone sodium, per 250 mg premiumpremium premiumpremium
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more premiumpremium premiumpremium
51741 Electronic assessment of bladder emptying premiumpremium premiumpremium
52000 Diagnostic exam of bladder and urethra using an endoscope premiumpremium premiumpremium
J9217 Leuprolide acetate (for depot suspension), 7.5 mg premiumpremium premiumpremium
51720 Instillation of anti-cancer drug into bladder premiumpremium premiumpremium
76942 Ultrasonic guidance for needle placement premiumpremium premiumpremium
51705 Simple change of bladder tube premiumpremium premiumpremium
55700 Biopsy of prostate gland premiumpremium premiumpremium
64566 Insertion of lower leg neurostimulator electrode premiumpremium premiumpremium
96372 Injection of drug or substance under skin or into muscle premiumpremium premiumpremium
74420 Imaging of urinary tract following injection of a contrast agent premiumpremium premiumpremium
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes premiumpremium premiumpremium
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes premiumpremium premiumpremium
51700 Simple bladder irrigation and/or instillation premiumpremium premiumpremium
55874 Injection of biodegradable material next to prostate premiumpremium premiumpremium
52356 Crushing of stone of ureter with insertion of stent using an endoscope premiumpremium premiumpremium
52332 Insertion of stent in ureter using an endoscope premiumpremium premiumpremium
76999 Other ultrasound procedure premiumpremium premiumpremium
51702 Simple insertion of temporary bladder tube premiumpremium premiumpremium
55876 Placement of device in prostate for radiation therapy premiumpremium premiumpremium
99442 Telephone medical discussion with physician, 11-20 minutes premiumpremium premiumpremium
52601 Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope premiumpremium premiumpremium
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle premiumpremium premiumpremium

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.